{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:37:10Z","timestamp":1792532230916,"version":"4.5.0"},"reference-count":138,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["NV18-03-00277"],"award-info":[{"award-number":["NV18-03-00277"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Natural killer cells possess key regulatory function in various malignant diseases, including acute myeloid leukemia. NK cell activity is driven by signals received through ligands binding activating or inhibitory receptors. Their activity towards elimination of transformed or virally infected cells can be mediated through MICA, MICB and ULBP ligands binding the activating receptor NKG2D. Given the efficiency of NK cells, potential target cells developed multiple protecting mechanisms to overcome NK cells killing on various levels of biogenesis of NKG2D ligands. Targeted cells can degrade ligand transcripts <jats:italic>via<\/jats:italic> microRNAs or modify them at protein level to prevent their presence at cell surface <jats:italic>via<\/jats:italic> shedding, with added benefit of shed ligands to desensitize NKG2D receptor and avert the threat of destruction <jats:italic>via<\/jats:italic> NK cells. NK cells and their activity are also indispensable during hematopoietic stem cell transplantation, crucial treatment option for patients with malignant disease, including acute myeloid leukemia. Function of both NKG2D and its ligands is strongly affected by polymorphisms and particular allelic variants, as different alleles can play variable roles in ligand-receptor interaction, influencing NK cell function and HSCT outcome differently. For example, role of amino acid exchange at position 129 in <jats:italic>MICA<\/jats:italic> or at position 98 in <jats:italic>MICB<\/jats:italic>, as well as the role of other polymorphisms leading to different shedding of ligands, was described. Finally, match or mismatch between patient and donor in NKG2D ligands affect HSCT outcome. Having the information beyond standard HLA typing prior HSCT could be instrumental to find the best donor for the patient and to optimize effects of treatment by more precise patient-donor match. Here, we review recent research on the NKG2D\/NKG2D ligand biology, their regulation, description of their polymorphisms across the populations of patients with AML and the influence of particular polymorphisms on HSCT outcome.<\/jats:p>","DOI":"10.3389\/fimmu.2021.651751","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T04:37:13Z","timestamp":1617079033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation"],"prefix":"10.3389","volume":"12","author":[{"given":"Alena","family":"Machuldova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Holubova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina S.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslava","family":"Cedikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Jindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Houdova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Pitule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,30]]},"reference":[{"key":"B1","unstructured":"Surveillance, epidemiology, and end results (SEER) program Cancer stat facts: Leukemia - acute myeloid leukemia (AML)2016"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1539617","DOI":"10.1080\/2162402X.2018.1539617","article-title":"Acute myeloid leukemia and NK cells: two warriors confront each other","volume":"8","author":"Baraga\u00f1o Raneros","year":"2019","journal-title":"Oncoimmunology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S191621","article-title":"Mechanisms of drug resistance in acute myeloid leukemia","volume":"12","author":"Zhang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.01.019","article-title":"Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses","volume":"15","author":"Gill","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"B5","first-page":"999","article-title":"Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells","volume":"9","author":"Bendall","year":"1995","journal-title":"Leukemia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.arcmed.2016.02.001","article-title":"Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia","volume":"47","author":"Sandoval-Borrego","year":"2016","journal-title":"Arch Med Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-027979","article-title":"Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction","volume":"109","author":"Fauriat","year":"2007","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2011.15","article-title":"Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients","volume":"90","author":"Sanchez-Correa","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.3390\/cancers12082171","article-title":"Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia","volume":"12","author":"Valhondo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.01.019","article-title":"Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade","volume":"16","author":"Godal","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-222190","article-title":"NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects","volume":"115","author":"Olson","year":"2010","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V67.3.722.722","article-title":"Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation","volume":"67","author":"Hercend","year":"1986","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-812630-1.00016-5","article-title":"Chapter 16 - Natural Killer Cells in GvHD and GvL","volume-title":"Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation (Second Edition)","author":"Arvindam","year":"2019"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00408","article-title":"NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses","volume":"3","author":"Zingoni","year":"2013","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.10.1505","article-title":"Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells","volume":"190","author":"Pende","year":"1999","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.7.1129","article-title":"p46, a novel natural killer cell-specific surface molecule that mediates cell activation","volume":"186","author":"Sivori","year":"1997","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.12.2065","article-title":"NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis","volume":"187","author":"Vitale","year":"1998","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.008318","article-title":"NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies","volume":"94","author":"Espinoza","year":"2009","journal-title":"Haematologica"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/85311","article-title":"Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A","volume":"2","author":"Wolan","year":"2001","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s1074-7613(02)00333-3","article-title":"The role of the NKG2D immunoreceptor in immune cell activation and natural killing","volume":"17","author":"Jamieson","year":"2002","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s002510050420","article-title":"The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex","volume":"48","author":"Glienke","year":"1998","journal-title":"Immunogenetics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5428.730","article-title":"An activating immunoreceptor complex formed by NKG2D and DAP10","volume":"285","author":"Wu","year":"1999","journal-title":"Science"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2776","article-title":"Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance","volume":"66","author":"Hayashi","year":"2006","journal-title":"Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2294-1","article-title":"NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib","volume":"106","author":"Hara","year":"2017","journal-title":"Int J Hematol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/s1471-4906(01)01960-3","article-title":"MICA and MICB genes: can the enigma of their polymorphism be resolved","volume":"22","author":"Stephens","year":"2001","journal-title":"Trends Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00476","article-title":"NKG2D and Its Ligands: \u201cOne for All, All for One\u201d","volume":"9","author":"Zingoni","year":"2018","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2006.56","article-title":"Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiation","volume":"38","author":"Kim","year":"2006","journal-title":"Exp Mol Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.2.961","article-title":"Promoter region architecture and transcriptional regulation of the genes for the MHC class I-related chain A and B ligands of NKG2D","volume":"178","author":"Venkataraman","year":"2007","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nature03884","article-title":"The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor","volume":"436","author":"Gasser","year":"2005","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a021242","article-title":"Isolation and characterization of retinoic acid-inducible cDNA clones in F9 cells: a novel cDNA family encodes cell surface proteins sharing partial homology with MHC class I molecules","volume":"119","author":"Zou","year":"1996","journal-title":"J Biochem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2585","article-title":"Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias","volume":"105","author":"Nowbakht","year":"2005","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.79","article-title":"MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue","volume":"116","author":"Ghadially","year":"2017","journal-title":"Br J Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20120565","article-title":"RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry","volume":"209","author":"Jung","year":"2012","journal-title":"J Exp Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/157339509787314369","article-title":"Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells","volume":"5","author":"Eagle","year":"2009","journal-title":"Curr Immunol Rev"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.71.5.791","article-title":"Activation-induced expression of MICA on T lymphocytes involves engagement of CD3 and CD28","volume":"71","author":"Molinero","year":"2002","journal-title":"J Leukoc Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2007.00539.x","article-title":"An association between the MICA-A5.1 allele and an increased susceptibility to oral squamous cell carcinoma in Japanese patients","volume":"36","author":"Tamaki","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00511","article-title":"Allele Facilitates the Metastasis of KRAS-Mutant Colorectal Cancer","volume":"11","author":"Ding","year":"2020","journal-title":"Front Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41435-018-0044-x","article-title":"MICA and NKG2D variants as risk factors in spondyloarthritis: a case-control study","volume":"20","author":"Fechtenbaum","year":"2019","journal-title":"Genes Immun"},{"key":"B40","article-title":"MICA polymorphisms and cancer risk: a meta-analysis","volume":"8","author":"Ji","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0065-2776(01)76018-x","article-title":"MIC genes: from genetics to biology","volume":"76","author":"Bahram","year":"2000","journal-title":"Adv Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.0960-7420.2001.00275.x","article-title":"Further polymorphism of the MICA gene","volume":"29","author":"P\u00e9rez-Rodr\u00edguez","year":"2002","journal-title":"Eur J Immunogenet"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.2000.550209.x","article-title":"A new MICA allele with ten alanine residues in the exon 5 microsatellite","volume":"55","author":"P\u00e9rez-Rodr\u00edguez","year":"2000","journal-title":"Tissue Antigens"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.052701099","article-title":"A basolateral sorting motif in the MICA cytoplasmic tail","volume":"99","author":"Suemizu","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1042\/BJ20130194","article-title":"A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008","volume":"454","author":"Ashiru","year":"2013","journal-title":"Biochem J"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.01.029","article-title":"Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA\u2217008 to Escape Elimination by NK Cells","volume":"10","author":"Seidel","year":"2015","journal-title":"Cell Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01175-09","article-title":"NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142","volume":"83","author":"Ashiru","year":"2009","journal-title":"J Virol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1161","article-title":"The IPD and IMGT\/HLA database: allele variant databases","volume":"43","author":"Robinson","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00314","article-title":"High-Throughput\u00a0MICA\/B\u00a0Genotyping of Over Two Million Samples: Workflow and Allele Frequencies","volume":"11","author":"Klussmeier","year":"2020","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3889\/MJMS.1857-5773.2013.0299","article-title":"MICA Polymorphism, Association with Diseases and the Role of Anti-MICA Antibodies in Organ and Stem Cell Transplantation","volume":"6","author":"Kirijas Or Paneva","year":"2013","journal-title":"Macedonian J Med Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s002510050655","article-title":"Population study of allelic diversity in the human MHC class I-related MIC-A gene","volume":"49","author":"Petersdorf","year":"1999","journal-title":"Immunogenetics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imr.12328","article-title":"Genetics, genomics, and evolutionary biology of NKG2D ligands","volume":"267","author":"Carapito","year":"2015","journal-title":"Immunol Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1006\/geno.2001.6673","article-title":"A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3","volume":"79","author":"Radosavljevic","year":"2002","journal-title":"Genomics"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.2.1078","article-title":"Two human ULBP\/RAET1 molecules with transmembrane regions are ligands for NKG2D","volume":"173","author":"Bacon","year":"2004","journal-title":"J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00620","article-title":"Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4","volume":"9","author":"Z\u00f6ller","year":"2018","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.1.207","article-title":"IMGT, the international ImMunoGeneTics database","volume":"29","author":"Lefranc","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.076042","article-title":"The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells","volume":"124","author":"Fern\u00e1ndez-Messina","year":"2011","journal-title":"J\u00a0Cell Sci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.077636","article-title":"Post-translational modification of the NKG2D ligand RAET1G leads to cell surface expression of a glycosylphosphatidylinositol-linked isoform","volume":"285","author":"Ohashi","year":"2010","journal-title":"J Biol Chem"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2012.03625.x","article-title":"The molecular determinants of CD8 co-receptor function","volume":"137","author":"Cole","year":"2012","journal-title":"Immunology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2013.01.030","article-title":"RAET1\/ULBP alleles and haplotypes among Kolla South American Indians","volume":"74","author":"Cox","year":"2013","journal-title":"Hum Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2010.02.018","article-title":"Single nucleotide polymorphism analysis of the NKG2D ligand cluster on the long arm of chromosome 6: Extensive polymorphisms and evidence of diversity between human populations","volume":"71","author":"Antoun","year":"2010","journal-title":"Hum Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-009-0394-7","article-title":"Polymorphisms of NKG2D ligands: diverse RAET1\/ULBP genes in northeastern Thais","volume":"61","author":"Romphruk","year":"2009","journal-title":"Immunogenetics"},{"key":"B63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/path.5097","article-title":"Integrating the DNA damage and protein stress responses during cancer development and treatment","volume":"246","author":"Gorgoulis","year":"2018","journal-title":"J Pathol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203015","article-title":"Regulation of p53 in response to DNA damage","volume":"18","author":"Lakin","year":"1999","journal-title":"Oncogene"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4161\/cc.10.19.17630","article-title":"Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2","volume":"10","author":"Li","year":"2011","journal-title":"Cell Cycle"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1977","article-title":"Tumor suppressive microRNAs miR-34a\/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D","volume":"72","author":"Heinemann","year":"2012","journal-title":"Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1642","article-title":"Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D","volume":"9","author":"Stern-Ginossar","year":"2008","journal-title":"Nat Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1410-1","article-title":"Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion","volume":"572","author":"Paczulla","year":"2019","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.001933","article-title":"Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes","volume":"94","author":"Gaymes","year":"2009","journal-title":"Haematologica"},{"key":"B71","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1158\/1078-0432.CCR-16-0984","article-title":"A Phase 1 Study of the PARP Inhibitor Veliparib in Combination with Temozolomide in Acute Myeloid Leukemia","volume":"23","author":"Gojo","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129168","article-title":"The PRIME Trial: PARP Inhibition in IDH Mutant Effectiveness Trial. a Phase II Study of Olaparib in Isocitrate Dehydrogenase (IDH) Mutant Relapsed\/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome","volume":"134","author":"Chandhok","year":"2019","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/cancers11101493","article-title":"Antileukemic Efficacy in Vitro of Talazoparib and APE1 Inhibitor III Combined with Decitabine in Myeloid Malignancies","volume":"11","author":"Kohl","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081335","article-title":"Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress","volume":"206","author":"Nice","year":"2009","journal-title":"J Exp Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.2792","article-title":"Lysine-targeting specificity in ubiquitin and ubiquitin-like modification pathways","volume":"21","author":"Mattiroli","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2010.00893.x","article-title":"Effect of NKG2D ligand expression on host immune responses","volume":"235","author":"Champsaur","year":"2010","journal-title":"Immunol Rev"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1042\/BST0360459","article-title":"Natural killer cell evasion by an E3 ubiquitin ligase from Kaposi\u2019s sarcoma-associated herpesvirus","volume":"36","author":"Thomas","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1339854","DOI":"10.1080\/2162402X.2017.1339854","article-title":"Soluble NKG2D ligands in the ovarian cancer microenvironment are associated with an adverse clinical outcome and decreased memory effector T cells independent of NKG2D downregulation","volume":"6","author":"Vyas","year":"2017","journal-title":"Oncoimmunology"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21382","article-title":"Soluble MICA in malignant diseases","volume":"118","author":"Holdenrieder","year":"2006","journal-title":"Int J Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M702504200","article-title":"RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity","volume":"282","author":"Cao","year":"2007","journal-title":"J Biol Chem"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6768","article-title":"Tumor-associated MICA is shed by ADAM proteases","volume":"68","author":"Waldhauer","year":"2008","journal-title":"Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903789","article-title":"The membrane type matrix metalloproteinase MMP14 mediates constitutive shedding of MHC class I chain-related molecule A independent of A disintegrin and metalloproteinases","volume":"184","author":"Liu","year":"2010","journal-title":"J Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2520","article-title":"Proteolytic release of soluble UL16-binding protein 2 from tumor cells","volume":"66","author":"Waldhauer","year":"2006","journal-title":"Cancer Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00447","article-title":"NKG2D Ligand Shedding in Response to Stress: Role of ADAM10","volume":"11","author":"Zingoni","year":"2020","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1042\/CBI20100431","article-title":"MMP9 mediates MICA shedding in human osteosarcomas","volume":"35","author":"Sun","year":"2011","journal-title":"Cell Biol Int"},{"key":"B86","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.semcancer.2014.02.010","article-title":"Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance","volume":"28","author":"Mincheva-Nilsson","year":"2014","journal-title":"Semin Cancer Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41598-019-56542-4","article-title":"Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells","volume":"10","author":"Sharma","year":"2020","journal-title":"Sci Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.045906","article-title":"Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands","volume":"285","author":"Fern\u00e1ndez-Messina","year":"2010","journal-title":"J Biol Chem"},{"key":"B89","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2006.03.002","article-title":"Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression","volume":"239","author":"Song","year":"2006","journal-title":"Cell Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1688","article-title":"Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes","volume":"70","author":"Ashiru","year":"2010","journal-title":"Cancer Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4049\/jimmunol.182.1.49","article-title":"Cutting edge: the metalloproteinase ADAM17\/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein","volume":"182","author":"Boutet","year":"2009","journal-title":"J Immunol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0669-2","article-title":"ADAM10 mediates malignant pleural mesothelioma invasiveness","volume":"38","author":"S\u00e9pult","year":"2019","journal-title":"Oncogene"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-0846-3","article-title":"Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP","volume":"10","author":"McCulloch","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2005.10.019","article-title":"Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma","volume":"245","author":"Ko","year":"2007","journal-title":"Cancer Lett"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0886","article-title":"Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B","volume":"15","author":"Paschen","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711293105","article-title":"MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma","volume":"105","author":"Jinushi","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200796","article-title":"Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses","volume":"189","author":"Hilpert","year":"2012","journal-title":"J Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.74","article-title":"The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia","volume":"24","author":"N\u00fcckel","year":"2010","journal-title":"Leukemia"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-01-0019","article-title":"Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia","volume":"102","author":"Salih","year":"2003","journal-title":"Blood"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2011.01748.x","article-title":"Positive association of major histocompatibility complex class I chain-related gene A polymorphism with leukemia susceptibility in the people of Han nationality of Southern China","volume":"78","author":"Luo","year":"2011","journal-title":"Tissue Antigens"},{"key":"B101","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41408-018-0092-5","article-title":"Association of MICA and MICB polymorphisms with the susceptibility of leukemia in Korean patients","volume":"8","author":"Baek","year":"2018","journal-title":"Blood Cancer J"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12072","article-title":"The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantation","volume":"159","author":"Antoun","year":"2012","journal-title":"Br J Haematol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017015230","article-title":"Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy","volume":"2","author":"Mastaglio","year":"2018","journal-title":"Blood Adv"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.20","article-title":"Hematopoietic stem cell transplantation in Europe 2014: more than 40\u2009000 transplants annually","volume":"51","author":"Passweg","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.4993.626","article-title":"Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication","volume":"2","author":"BARNES","year":"1956","journal-title":"Br Med J"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1038\/bcj.2011.14","article-title":"Long-term complications and side effects after allogeneic hematopoietic stem cell transplantation: an update","volume":"1","author":"Mohty","year":"2011","journal-title":"Blood Cancer J"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.seminhematol.2005.09.001","article-title":"Pathophysiology of graft-versus-host disease","volume":"43","author":"Ferrara","year":"2006","journal-title":"Semin Hematol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2019.05.014","article-title":"Review of Graft-Versus-Host Disease","volume":"37","author":"Ramachandran","year":"2019","journal-title":"Dermatol Clin"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703111","article-title":"Chronic graft-versus-host disease: clinical manifestation and therapy","volume":"28","author":"Ratanatharathorn","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.11483","article-title":"Acute Graft","volume":"37","author":"Nassereddine","year":"2017","journal-title":"Anticancer Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1365-2141.2005.05614.x","article-title":"Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation","volume":"130","author":"P\u00e9rez-Sim\u00f3n","year":"2005","journal-title":"Br J Haematol"},{"key":"B113","article-title":"Targeting Cytokines in GVHD Therapy","volume":"2","author":"Kumar","year":"2017","journal-title":"J Immunol Res Ther"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-340315","article-title":"Prevention of GVHD while sparing GVL effect by targeting Th1 and Th17 transcription factor T-bet and ROR\u03b3t in mice","volume":"118","author":"Yu","year":"2011","journal-title":"Blood"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/hon.716","article-title":"Pathophysiology of acute graft-versus-host disease","volume":"21","author":"Reddy","year":"2003","journal-title":"Hematol Oncol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2017.09.003","article-title":"Which factors influence the development of GVHD in HLA-matched or mismatched transplants","volume":"30","author":"Petersdorf","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-171934","article-title":"HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism","volume":"113","author":"Kawase","year":"2009","journal-title":"Blood"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00041","article-title":"Reduction of Relapse after Unrelated Donor Stem Cell Transplantation by KIR-Based Graft Selection","volume":"8","author":"Heidenreich","year":"2017","journal-title":"Front Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201505246","article-title":"The MICA-129 dimorphism affects NKG2D signaling and outcome of hematopoietic stem cell transplantation","volume":"7","author":"Isernhagen","year":"2015","journal-title":"EMBO Mol Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-716357","article-title":"Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation","volume":"128","author":"Fuerst","year":"2016","journal-title":"Blood"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-05-223172","article-title":"Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease","volume":"114","author":"Parmar","year":"2009","journal-title":"Blood"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-719070","article-title":"Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD","volume":"128","author":"Carapito","year":"2016","journal-title":"Blood"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.58","article-title":"Chronic GVHD is associated with inferior relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors","volume":"47","author":"Signori","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703735","article-title":"The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors","volume":"30","author":"Remberger","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-04-217430","article-title":"MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease","volume":"114","author":"Boukouaci","year":"2009","journal-title":"Blood"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00380","article-title":"Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes","volume":"8","author":"Gam","year":"2017","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001927","article-title":"Recipient and donor genetic variants associated with mortality after allogeneic hematopoietic cell transplantation","volume":"4","author":"Martin","year":"2020","journal-title":"Blood Adv"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2019.10.001","article-title":"Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation","volume":"13","author":"Patel","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-015-0884-8","article-title":"The MICA-129Met\/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA","volume":"68","author":"Isernhagen","year":"2016","journal-title":"Immunogenetics"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0886-5","article-title":"Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status","volume":"55","author":"Carapito","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aai8904","article-title":"A disease-linked\u00a0ULBP6\u00a0polymorphism inhibits NKG2D-mediated target cell killing by enhancing the stability of NKG2D ligand binding","volume":"10","author":"Zuo","year":"2017","journal-title":"Sci Signal"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01820","article-title":"The Biological Influence and Clinical Relevance of Polymorphism Within the NKG2D Ligands","volume":"9","author":"Zuo","year":"2018","journal-title":"Front Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1002\/art.30501","article-title":"Role of the MICA polymorphism in systemic lupus erythematosus","volume":"63","author":"Yoshida","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.24041","article-title":"Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism","volume":"120","author":"Norris","year":"2001","journal-title":"Gastroenterology"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel331","article-title":"MHC class I chain-related gene B (MICB) is associated with rheumatoid arthritis susceptibility","volume":"46","author":"L\u00f3pez-Arbesu","year":"2007","journal-title":"Rheumatol (Oxford)"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.651751\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T04:37:20Z","timestamp":1617079040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.651751\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,30]]},"references-count":138,"alternative-id":["10.3389\/fimmu.2021.651751"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.651751","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,30]]},"article-number":"651751"}}